Evidence Hub

Warfarin - Fluoroquinolones, Sulfonamides, or Azole Antifungals Interactions and the Risk of Hospitalization for Gastrointestinal Bleeding

H. Schelleman, Warren B. Bilker, Colleen M. Brensinger, Xiaoyan Han, Stephen E. Kimmel, Sean Hennessy

Clinical pharmacology and therapy, 2008

122 citations

Abstract

The aim of this study was to determine whether a potential pharmacokinetic interaction between warfarin and orally administered anti‐infectives increases the risk of hospitalization for gastrointestinal (GI) bleeding in warfarin users. We conducted a nested case–control and case–crossover study using US Medicaid data. Logistic regression was used to determine the association between GI bleeding and prior use of ciprofloxacin, levofloxacin, gatifloxacin, co‐trimoxazole, or fluconazole vs. no exposure and also vs. use of cephalexin, which would not be expected to interact with warfarin. All of the anti‐infectives examined were associated with elevated odds ratios (ORs) when compared to no exposure to these drugs. With cephalexin data as the reference, the ORs for co‐trimoxazole (OR: 1.68 (95% confidence interval (CI): 1.21–2.33) in the prior 6–10 days) and fluconazole (OR: 2.09 (95% CI: 1.34–3.26) in the prior 11–15 days) were significantly elevated. Warfarin users who had received an anti‐infective agent showed a substantially increased risk of GI bleeding. However, a drug–drug interaction with warfarin was evident only for co‐trimoxazole and fluconazole.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free